Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2859)
All Articles published online
|
Mar 14, 2008 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang LB, Jiang ZN, Fan MY, Xu CY, Chen WJ, Shen JG. Changes of histology and expression of MMP-2 and nm23-H1 in primary and metastatic gastric cancer. World J Gastroenterol 2008; 14(10): 1612-1616 [PMID: 18330957 DOI: 10.3748/wjg.14.1612] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i10/1612.htm |
| Number | Citing Articles |
| 1 |
Shailendra Kapoor. Matrix metalloproteinase‐2 (MMP‐2): A major player in the progression of systemic malignancies besides endometrial serous carcinomas. Acta Obstetricia et Gynecologica Scandinavica 2008; 87(11): 1259 doi: 10.1080/00016340802356917
|
| 2 |
Katarzyna Kamińska, Cezary Szczylik, Zofia F. Bielecka, Ewa Bartnik, Camillo Porta, Fei Lian, Anna M. Czarnecka. The role of the cell–cell interactions in cancer progression. Journal of Cellular and Molecular Medicine 2015; 19(2): 283 doi: 10.1111/jcmm.12408
|
| 3 |
Daniel Cordeiro Gurgel, José Telmo Valença-Junior, Conceição Aparecida Dornelas, Renato Braga Vieira, João Tarcisio Alves Maia-Filho, Roberto Cesar Pereira Lima-Junior, Ronaldo Albuquerque Ribeiro, Paulo Roberto Carvalho Almeida. Immunoexpression of Metalloproteinases 2 and 14 and TIMP-2 Inhibitor in Main Types of Primary Gastric Carcinomas and Lymph Node Metastasis. Pathology & Oncology Research 2015; 21(1): 73 doi: 10.1007/s12253-014-9790-x
|
| 4 |
Cheng‑Hung Chuang, Li‑Yu Wang, Yuen Wong, En‑Shyh Lin. Anti-metastatic effects of isolinderalactone via the inhibition of MMP-2 and up regulation of NM23-H1 expression in human lung cancer A549 cells. Oncology Letters 2018; doi: 10.3892/ol.2018.7862
|
| 5 |
Xiaojun Liu, Lianxing Li, Lihong Peng, Bo Wang, Jidong Lang, Qingqing Lu, Xizhe Zhang, Yi Sun, Geng Tian, Huajun Zhang, Liqian Zhou. Predicting Cancer Tissue-of-Origin by a Machine Learning Method Using DNA Somatic Mutation Data. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00674
|
| 6 |
Chengying Liu, Jun Liu, Xin Wang, Weidong Mao, Lian Jiang, Hua Ni, Mingcong Mo, Wei Wang. Prognostic impact of nm23‐H1 and PCNA expression in pathologic stage I non‐small cell lung cancer. Journal of Surgical Oncology 2011; 104(2): 181 doi: 10.1002/jso.21944
|
| 7 |
Zhong-Sheng Zhao, Yuan-Yu Wang, Yong-Quan Chu, Zai-Yuan Ye, Hou-Quan Tao. SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients. Clinical Cancer Research 2010; 16(1): 260 doi: 10.1158/1078-0432.CCR-09-1247
|
| 8 |
Robert Partyka, Maciej Gonciarz, Przemysław Jałowiecki, Danuta Kokocińska, Tomasz Byrczek. VEGF and metalloproteinase 2 (MMP 2) expression in gastric cancer tissue. Medical Science Monitor 2012; 18(4): BR130 doi: 10.12659/MSM.882614
|
| 9 |
Fereshte Bibak, Samane Ahmadi, Zeynab Khateri, Amirhossein Ahmadi, Kheirollah Yari. The Role of Matrix Metalloproteinase-2 Expression in Gastric Cancer Susceptibility: A Systematic Review. International Journal of Cancer Management 2019; 12(9) doi: 10.5812/ijcm.94185
|
| 10 |
Sol de la Peña, Clara Luz Sampieri, Mariana Ochoa-Lara, Kenneth León-Córdoba, José María Remes-Troche. Expression of the Matrix Metalloproteases 2, 14, 24, and 25 and Tissue Inhibitor 3 as Potential Molecular Markers in Advanced Human Gastric Cancer. Disease Markers 2014; 2014: 1 doi: 10.1155/2014/285906
|
| 11 |
Nigel P. Murray. The role of matrix metalloproteinase-2 in the metastatic cascade: a review. Oncologie 2024; 26(1): 27 doi: 10.1515/oncologie-2023-0368
|
| 12 |
He-Ling Wang, Ping-Yi Zhou, Yu Zhang, Peng Liu. Relationships Between Abnormal MMP2 Expression and Prognosis in Gastric Cancer: A Meta-Analysis of Cohort Studies. Cancer Biotherapy and Radiopharmaceuticals 2014; 29(4): 166 doi: 10.1089/cbr.2014.1608
|
| 13 |
Y. Zou, J. Li, Z. Chen, X. Li, S. Zheng, D. Yi, A. Zhong, J. Chen. miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients. Carcinogenesis 2015; 36(6): 676 doi: 10.1093/carcin/bgv027
|
| 14 |
Choon-Yee Tan, Christina L Chang. NDPKA is not just a metastasis suppressor – be aware of its metastasis-promoting role in neuroblastoma. Laboratory Investigation 2018; 98(2): 219 doi: 10.1038/labinvest.2017.105
|